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In vivo estimation of septal lung tissue volume and
correlation with diffusing capacity in lung volume
reduction surgery
To the Editor
We read with great interest the recent paper by J. C. Chen
and associates1 about the diffusing capacity limitations of the
extent of lung volume reduction surgery (LVRS) in animal
models of emphysema. The authors induced diffuse emphy-
sema by aerosol elastase, a model similar to the homogenous
type of human emphysema. However, patients with emphyse-
ma who are good candidates for LVRS tend to have hetero-
geneous targeted areas for resection,2 as Cooper has men-
tioned.1 In these patients, improvement in respiratory system
compliance is prominent even after resection of a large vol-
ume of the lung. In contrast, diffusing capacity deteriorated
when the resected volume exceeded a threshold. In the setting
of major lung resection, diffusing capacity may predict the
postoperative morbidity and mortality.3 We believe that the
importance of diffusing capacity in LVRS needs to be empha-
sized. The goal of LVRS should be a balance between
improving mechanical function of the lung and diaphragm
without excessive loss of diffusing capacity or of the pul-
monary vascular bed. We congratulate Chen and associates
for raising this important issue.
In Dallas, we4,5 have performed extensive studies to deter-
mine the diffusion limitation after major lung resection at rest
and during exercise. Here, we would like to introduce a method
of assessing the diffusing capacity and septal lung tissue vol-
ume in vivo using combined radiologic and physiologic tech-
niques. We believe this approach has potentially important
applications in LVRS. With the use of an acetylene and a car-
bon monoxide rebreathing method, lung air volume, tissue vol-
ume, diffusing capacity, and cardiac output can be simultane-
ously and noninvasively measured.4 In addition, tissue volume
and air volume were also separately estimated by computed
tomographic (CT) scan, from which topologic distribution of
tissue and air volumes are obtained.6 We compared tissue vol-
ume measured by these 2 techniques in immature dogs at dif-
ferent ages. Half the dogs had undergone resection of the right
lung; the other half had undergone thoracotomy without lung
resection. We6 found significant correlations (P < .01) between
tissue volume measured by CT and rebreathing and between
tissue volume and diffusing capacity in both groups (Fig 1, A
and B). These data suggest that tissue volume is an anatomic
correlate of gas exchange capacity.
The article by Chen and associates reinforces the point that
the key functional parameter of gas exchange is not total lung
volume, but diffusing capacity and tissue volume. Measure-
ment of diffusing capacity and tissue volume may aid the
functional evaluation of patients with emphysema, although
their predictive value in the setting of LVRS requires further
investigation. For example, preoperative measurement of dif-
fusing capacity and tissue volume by the rebreathing method
could identify patients with insufficient gas exchange
reserves who would not benefit from LVRS regardless of
improvements in mechanical lung and respiratory muscle
function. In addition, one could potentially use CT scan to
map out the topologic distribution of tissue volume and to tar-
get regions with a low tissue volume (high air/tissue volume
ratio) for resection.
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Fig 1. Measurement of tissue volume and diffusing capacity by computed tomography and rebreathing. Vt, Tissue
volume; RB, rebreathing; CT, computed tomography; DLCO, diffusing capacity of carbon monoxide.
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Pulmonary surfactant and cardiopulmonary bypass
in infants 
To the Editor:
We read with interest the recent article by Paul and col-
leagues1 describing changes in pulmonary surfactant after
cardiopulmonary bypass (CPB) in a group of infants having
surgery for congenital heart disease.
In this article the authors report concentrations of phos-
pholipid and, indirectly, protein in returned fluid from tra-
cheal lavage. There is no apparent attempt to correct concen-
trations for variable recovery of epithelial lining fluid in these
specimens. To define the concentration of surfactant compo-
nents in sampled secretions, a marker of dilution should be
used, allowing the result to be expressed as concentration in
epithelial lining fluid.2 Results expressed as concentrations in
raw lavage fluid are impossible to interpret meaningfully.
Paul and colleagues do report the phospholipid/protein
ratio of tracheal lavage specimens. This ratio does nothing to
clarify the data and certainly cannot be interpreted as an
attempt to correct for dilution, given their later statement that
alveolar protein concentration is known to be increased after
CPB. A useful marker of dilution of epithelial lining fluid
must not be present in increased concentration in the dam-
aged lung. For this reason protein (along with albumin and
sphingomyelin) is not suitable in this population.3
Paul and colleagues report a significant fall in total phos-
pholipid concentration immediately after CPB. In their dis-
cussion they state: “Our data support the findings of
McGowan and colleagues, who demonstrated an alteration in
surfactant composition in older infants and children after
CPB.” In fact, these findings are at odds with those of
McGowan and colleagues,4 who found no difference in total
phosphatidylcholine recovered by bronchoalveolar lavage
before and after CPB. In the other published study looking at
phospholipid after CPB in children, LeVine and colleagues5
showed no difference in phosphatidylcholine levels between
a group of children who had undergone CPB and a control
group. Both of these studies involved greater numbers of
patients having CPB than in that of Paul and colleagues, and
both are also subject to the same criticism of not appropriately
correcting results for dilution.
There may well be significant abnormalities of pulmonary
surfactant that contribute to postoperative lung dysfunction in
this patient population. McGowan and colleagues4 did find a
change in the proportion of phospholipid in pulmonary sur-
factant subtypes after CPB (a measurement not influenced by
dilution of specimens), which would have important func-
tional implications. This subject warrants further investiga-
tion, but care must be taken to express findings in a way that
will add to our understanding of the consequences of CPB on
the composition and function of pulmonary surfactant.
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Reply to the Editor:
We thank Millar and colleagues for their interest in our arti-
cle, “The Role of Cardiopulmonary Bypass and Surfactant in
Pulmonary Decompensation after Surgery for Congenital
Heart Disease.”1 We concur that our data have certain limita-
tions and must be interpreted with a degree of caution.
Although we did not account for the variable recovery of
epithelial lining fluid by using a marker of dilution, we made
every effort to standardize the timing and technique of the
lavage fluid with each procedure. Although a measurement of
dilution may have been helpful, even this method has poten-
tial limitations2 and, as mentioned in the letter, our method is
similar to that used in other studies in children undergoing
bypass for congenital heart disease.3,4 Millar and colleagues
also pointed out the potential limitations to using total protein
as the denominator. However, as stated in our conclusions, we
